As we start the new academic year today, I am delighted to do so as Professor of Synthetic Chemistry. Thank you to all of the former and current group members and collaborators, and the supportive colleagues, mentors and reviewers I have been fortunate to work with
Announcing New frontiers in synthetic chemistry 2024.
Connect with the #SyntheticChemistry community and discuss recent advances at New frontiers in synthetic chemistry, organised with @AstraZeneca.
Find out more: rsc.li/3Sy6x68
Holy Smokes, the Marsh Family has put out this parody song about J.D. Vance and not only is it catchy but it hits the nail on the head…
“Anti Trump a few years ago,
Called him out as a ‘Hitler’ show.
Now you’re playing his sidekick,
Kissing Donald’s ring”
I watched it 70 times.
@MarshSongs
⚗️Explore our newest Special Issue, focused on the first deliveries of sufficient amounts of an active pharmaceutical ingredient (API) to support clinical studies. Read the latest research on this pivotal stage in drug development: pubs.acs.org/toc/oprdfk/28/…
Art by @marcmakescomics
Today's special issue of #OPRD focuses on the first deliveries of sufficient amounts of an active pharmaceutical ingredient (API) to support clinical studies.
Shout-out to Marc Jackson (@MARCmakescomics) for the front cover!
Read the new issue here! go.acs.org/9UL
Goundry (@WillGoRow) and coworkers from AstraZeneca have reported the first and second generation synthesis of TOPO 1 inhibitor AZ14170133 for use as an ADC Payload. They doubled the yield and reduced the PMI by 66%! Check it out here: pubs.acs.org/doi/10.1021/ac…